Synonym |
Hydrin 1%, (Arg8,Gly10,Lys11)-Vasotocin |
Species |
Human |
Protein Accession |
P01185 |
Purity |
Greater than 95% |
Endotoxin Level |
Less than 1 EU/ug |
Biological Activity |
Not specified |
Expression System |
Not specified |
Fusion Tag |
None |
Predicted Molecular Mass |
1043.21 Da |
Formulation |
Lyophilized from a 0.2 µm filtered solution in Acetonitrile and TFA |
Reconstitution |
Reconstitute in water to a concentration of 0.1-1.0 mg/ml |
Storage & Stability |
Store at -20°C or below. After reconstitution, store at 4°C for short-term storage or -20°C for
long-term storage. |
FAQ
What is Hydrin 1 and what are its primary functions within biological systems?
Hydrin 1, known
scientifically as (Arg8,Gly10,Lys11)-Vasotocin, is a peptide hormone belonging to the family of
neurohypophysial hormones. This compound serves various functions, primarily within neuroendocrine
signaling pathways. The structure of Hydrin 1 combines elements of both vasopressin and oxytocin, two
well-known peptides, allowing it to exert effects similar to these hormones but with distinct functions
due to its unique amino acid configuration. The presence of specific amino acids such as arginine,
glycine, and lysine at specific positions in Hydrin 1’s sequence is responsible for its unique
properties and biological activities.
In biological systems, Hydrin 1 is primarily involved in
modulating water and ion homeostasis, which is crucial for maintaining the internal environment of an
organism. It can affect kidney function by influencing water reabsorption, essentially playing a role in
the antidiuretic activity which helps organisms regulate their water balance under various conditions.
This is highly beneficial for species that experience fluctuating environmental water conditions,
allowing them to maintain homeostasis despite external changes in water availability.
Beyond
water balance, Hydrin 1 also influences reproductive and social behaviors, much like its related
peptides. The hormone interacts with specific receptors in the brain and other tissues, influencing
behaviors related to mating, nurturing, and other social interactions. It can modulate not only
physiological responses but also alter behaviors to adapt to social environmental changes, showcasing
its dual role as both a physiological regulator and a behavior modulator.
Moreover, Hydrin 1 can
impact cardiovascular functions. Acting on the cardiovascular system, it can influence blood pressure
and vascular resistance through its action on smooth muscle cells in blood vessels. This underlines its
potential importance in managing cardiovascular health, albeit indirectly through its primary roles in
water balance and homeostasis.
Research into Hydrin 1 has revealed its potential therapeutic
applications, especially in areas related to renal and cardiovascular health. Its multifunctionality
within different biological systems makes it an attractive candidate for further studies. Understanding
its dynamics could lead to breakthroughs in treating conditions related to its pathways, such as certain
types of diabetes insipidus, heart diseases, and disorders related to stress and behavior.
What
are the comparative benefits of using (Arg8,Gly10,Lys11)-Vasotocin over other vasopressin-like peptides?
(Arg8,Gly10,Lys11)-Vasotocin, or Hydrin 1, offers unique benefits over other vasopressin-like
peptides due to its distinct structural and functional properties. When comparing Hydrin 1 to its
relatives such as vasopressin and oxytocin, one must consider several crucial factors, including
specificity, receptor affinity, and multifunctionality within different physiological
systems.
Firstly, the structural uniqueness of Hydrin 1, particularly its amino acid sequence
that includes arginine, glycine, and lysine at key positions, gives it a unique receptor affinity. This
means that Hydrin 1 can bind to specific receptors with different affinities compared to other similar
peptides, potentially leading to a more targeted biological response. This kind of specificity can be
advantageous when designing treatments that require precise receptor interaction, minimizing unintended
effects on non-target receptors that are common with broader-spectrum analogs like
vasopressin.
The presence of glycine and lysine in Hydrin 1's structure also contributes to its
unique potency and efficacy in regulating water and ion balance within the body. These amino acids may
influence how the peptide interacts with receptor sites on kidney cells, leading to more efficient or
prolonged responses in water reabsorption and ion regulation. This could have significant implications
for individuals or species living in environments with varying water availability, providing a more
robust mechanism for maintaining internal homeostasis.
Moreover, Hydrin 1 can exert a range of
actions beyond those seen in peptides like vasopressin that are largely limited to antidiuretic and
vasoconstriction functions. The hormone not only plays a role in water balance but also influences
social and reproductive behaviors. Its impact on these behaviors may be likened to oxytocin, extending
Hydrin 1's role beyond mere physiological regulation to include effects on higher brain functions and
behavioral adaptations.
The cardiovascular effects of Hydrin 1 also set it apart. It influences
blood pressure and vascular resistance, offering potential benefits in the regulation of cardiovascular
health. This dual action—balancing both water retention and blood flow regulation—highlights its
versatility compared to vasopressin, which is primarily known for its antidiuretic and vasopressor
activities.
When considering therapeutic uses, these multi-system effects of Hydrin 1 suggest
that it could provide more comprehensive treatment strategies. Conditions linked to water retention,
stress-related cardiovascular disorders, and social behavior abnormalities might all benefit from
interventions using Hydrin 1, given its broader scope of action. Thus, Hydrin 1 offers a pharmacological
profile that provides not only specificity and efficacy but also multifunctionality that can be
harnessed in various medical contexts compared to other vasopressin-like peptides.
How does
Hydrin 1 impact physiological stress responses compared to traditional stress hormones?
Hydrin 1,
while primarily recognized for its role in water balance and social behavior, also contributes
significantly to the modulation of physiological stress responses. When comparing Hydrin 1's impact on
stress responses to traditional stress hormones like cortisol and adrenaline, several distinctions
highlight its unique role in stress physiology.
Traditional stress hormones like cortisol and
adrenaline are crucial components of the organism's immediate and long-term response to stress. They are
involved in the classic fight-or-flight response, increasing heart rate, boosting energy availability,
and modulating immune function and inflammation. These hormones prepare the body to react swiftly to
acute stressors and regulate longer-term adaptations to ongoing stress.
In contrast, Hydrin 1
influences stress responses more subtly, acting as a modulator rather than an instigator of these
reactions. Its primary connection to stress lies in its ability to influence the central nervous system
and affect behaviors associated with stress. One of the key mechanisms through which Hydrin 1 impacts
stress responses is through its action on neuroreceptors associated with emotional and social behaviors.
By interacting with these receptors, Hydrin 1 can attenuate stress-induced behaviors and promote social
bonding and cooperation, which are critical for resilience against social
stressors.
Additionally, Hydrin 1’s role in water and ion homeostasis can indirectly impact
stress physiology. Proper hydration and ion balance are essential for maintaining physiological
stability, particularly during stressful conditions. By ensuring these balances are maintained, Hydrin 1
helps mitigate the internal physiological disruptions that stress can cause, thus stabilizing the body's
response systems.
Interestingly, Hydrin 1 may also play a role in modulating the release of other
hormones involved in stress. For instance, by influencing vasopressin pathways, which are closely linked
to cortisol secretion, Hydrin 1 could alter the intensity and duration of stress hormone release in
prolonged stress situations. This suggests a regulatory role where Hydrin 1 fine-tunes the stress
hormone response, potentially reducing the risks associated with chronic stress such as hypertension,
metabolic imbalances, and immune dysfunction.
Moreover, the social aspect of stress is another
domain where Hydrin 1 shines. By promoting social interaction and cooperative behaviors during stress,
Hydrin 1 could enhance social support networks, which are recognized modifiers of stress impact. Strong
social bonds have been shown to lessen the perception of stress and improve overall psychological
resilience, which Hydrin 1 can potentiate through its neurobehavioral effects.
Thus, while Hydrin
1 does not trigger the primary physiological changes associated with stress like cortisol or adrenaline,
its modulatory effects on stress pathways and behaviors provide an additional layer of regulation. This
highlights the potential of Hydrin 1 as a therapeutic target in stress-related disorders, especially
those involving social stress and maladaptive social behaviors, offering an approach to stress
management that considers both physiological and social factors.
Can Hydrin 1 play a role in
therapeutic applications, particularly in mind-body health and behavioral therapies?
Hydrin 1's
multifaceted physiological roles suggest promising potential for therapeutic applications, especially in
areas concerning mind-body health and behavioral therapies. As research progresses, Hydrin 1 could
emerge as a critical compound in developing novel treatments that bridge the gap between physiological
regulation and psychological well-being.
One of the key aspects of Hydrin 1 that makes it
particularly suited for therapeutic applications is its dual role in regulating physiological functions
such as water balance and influencing social and emotional behaviors. This duality provides a unique
opportunity for developing therapies that target both mind and body simultaneously. In mind-body health,
where the interplay between psychological states and physical health is critical, Hydrin 1's ability to
exert calming effects and modulate stress responses could be harnessed to enhance overall
well-being.
In behavioral therapies, Hydrin 1 could be particularly useful given its influence on
social behaviors. Conditions such as autism spectrum disorders or social anxiety, where social
interaction and communication are impaired, might benefit from therapies incorporating Hydrin 1 to
promote social bonding and reduce anxiety associated with social interactions. The potential of Hydrin 1
to alter neurochemical pathways underlying social behaviors paves the way for innovative treatment
approaches that could enhance social functioning in individuals struggling with these
disorders.
Moreover, Hydrin 1's impact on stress regulation presents further therapeutic
possibilities. Many chronic conditions, including cardiovascular diseases, diabetes, and some mental
health disorders, are exacerbated by stress. By modulating stress responses and promoting relaxation,
Hydrin 1 has the potential to be integrated into therapies focused on stress reduction and resilience
building. Techniques such as mindfulness and cognitive-behavioral therapy, already known to benefit from
physiological relaxation responses, could be enhanced by Hydrin 1's biochemical support for stress
management.
Another promising area for Hydrin 1's application lies in its cardiovascular effects.
Given its ability to modulate vascular and blood pressure responses, incorporating Hydrin 1 into
treatments for hypertension or other cardiovascular issues could complement existing therapies. These
cardiovascular benefits could also support overall health improvement when integrated with lifestyle
interventions targeting diet and exercise, potentially offering a holistic approach to managing heart
health.
Moreover, Hydrin 1 may support therapeutic strategies focusing on hydration and skin
health, particularly in disorders where hydration is compromised. Its role in regulating water balance
is crucial, not only for kidney function but also for maintaining proper skin hydration and elasticity,
which are important for skin health and conditions like eczema or psoriasis.
In essence, the
versatility of Hydrin 1 in influencing both physiological and psychological domains makes it a
compelling candidate for future therapeutic development. Its broad range of action underscores its
potential for creating integrated treatment modalities that address complex health issues where
mind-body interplay is significant. As research continues to elucidate its mechanisms of action, Hydrin
1 could become a cornerstone in personalized medicine approaches, aiming to improve quality of life by
harmonizing physiological balance and mental health.